Skip to content

Pediatric Pneumonia Lung Ultrasound

Evaluation of Impact of Lung Ultrasound (LUS) on Management of Pneumonia in Low-resource Settings

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03187067
Acronym
PLUS
Enrollment
270
Registered
2017-06-14
Start date
2017-07-31
Completion date
2019-01-08
Last updated
2019-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Infection, Pneumonia

Keywords

pneumonia, diagnostic, ultrasound, Pakistan, Mozambique

Brief summary

The purpose of this study is to evaluate the impact of LUS on the diagnosis and management of childhood pneumonia in developing countries

Interventions

DEVICELung ultrasound

Lung ultrasound will be performed on all children to investigate imaging patterns characteristic of pneumonia.

Sponsors

Bill and Melinda Gates Foundation
CollaboratorOTHER
Barcelona Institute for Global Health
CollaboratorOTHER
Aga Khan University
CollaboratorOTHER
Save the Children
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
2 Months to 23 Months
Healthy volunteers
No

Inclusion criteria

(chest indrawing cases): * Male or female, 2 through 23 months of age * Cough \<14 days or difficulty breathing * Visible indrawing of the chest wall, with or without fast breathing * Ability and willingness of child's caregiver to provide informed consent and to be available for follow-up for the planned duration of the study, including accepting a home visit if he/she fails to return to the study facility for a scheduled follow-up visit Inclusion Criteria (non-chest indrawing controls): * Male or female, 2 through 23 months of age * Cough \<14 days or difficulty breathing * Ability and willingness of child's caregiver to provide informed consent and to be available for follow-up for the planned duration of the study, including accepting a home visit if he/she fails to return to the study facility for a scheduled follow-up visit

Design outcomes

Primary

MeasureTime frame
LUS findings at enrollment8 hours

Secondary

MeasureTime frame
Repeat LUS findings30 days

Countries

Mozambique, Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026